Related Experiment Video

Updated: Aug 6, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Hypoglycaemia of the newborn: a review

A F Williams1

  • 1St George's Health Care Trust, St George's Hospital, London, England.

Bulletin of the World Health Organization
|January 1, 1997
PubMed

Insights

Neonatal hypoglycemia, a condition of low blood glucose in newborns, remains controversial despite decades of study. This review clarifies its definition, significance, and management, offering recommendations for prevention and treatment.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Biochemistry

Background:

  • Hypoglycemia (low blood glucose) in newborns has been recognized for over 50 years, yet its definition, significance, and management remain debated.
  • Technological advancements like bedside glucose monitoring have complicated, rather than simplified, the approach to neonatal hypoglycemia.
  • Understanding glucose homeostasis and metabolic adaptation at birth is crucial for neonatal care.

Purpose of the Study:

  • To provide a comprehensive review of the existing literature on neonatal hypoglycemia.
  • To address the controversies surrounding the definition, significance, and management of this condition in newborns.
  • To offer evidence-based recommendations for the prevention and management of hypoglycemia in neonates.

Main Methods:

  • Systematic review of the literature on neonatal hypoglycemia.
  • Analysis of historical data and current research on glucose metabolism in newborns.
  • Examination of the impact of low blood glucose on the neonatal central nervous system.

Main Results:

  • The definition, significance, and management of neonatal hypoglycemia are still subjects of ongoing controversy.
  • Bedside glucose monitoring technologies have paradoxically increased the complexity of managing neonatal hypoglycemia.
  • The review covers historical context, glucose homeostasis, neurological effects, definition, screening, prevention, and treatment.

Conclusions:

  • Clearer definitions and standardized screening protocols are needed for neonatal hypoglycemia.
  • Effective prevention and management strategies require a multidisciplinary approach.
  • Further research is essential to resolve current controversies and improve outcomes for affected infants.

More Related Videos

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy10:30

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy

Published on: May 16, 2015

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...